1. News
April 20, 2020

Covid-19: Lenox to shut Kinston bone china factory in US

US tableware, giftware and home entertaining company Lenox has revealed its decision to shut down its bone china factory in Kinston, North Carolina, due to the Covid-19 pandemic.

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.

US tableware, giftware and home entertaining company Lenox has revealed its decision to shut down its bone china factory in Kinston, North Carolina, due to the Covid-19 pandemic.

Constructed in 1989, the 218,000ft² Kinston factory manufactures fine bone china dinnerware patterns in the US.

The facility features several manufacturing capabilities such as hand-enamelled dots, etching techniques and microwave-safe metals. Nine patterns produced by the factory list in the company’s top ten.

The plant is capable of manufacturing 15,000 to 20,000 pieces of fine china a day.

Content from our partners
Advanced analytics and predicting market trends in FMCG
How smart predictive analytics is shaping product development
Data analysis in the brave new world

Lenox CEO Mads Ryder said: “It has been a very difficult decision to decide to close the factory. It is closing a chapter in Lenox’s long and illustrious history as an American manufacturer of fine dinnerware products.

“These achievements were only made possible by the competent, dedicated and proud team of the Kinston factory.”

Despite the closure, Lenox will keep on designing and developing its ‘heritage patterns’ in the US and produce in Europe and Asia.

Headquartered in Bristol, Pennsylvania, Lenox’s products are traded under various brands, including Lenox, Dansk, and Reed & Barton brands.

Products are sold via its own retail stores and consumer-direct channels, as well as Internet and catalogue.

It is also involved in making and supplies Kate Spade New York, Marchesa by Lenox and Brian Gluckstein by Lenox brands and more.

Confirmed cases on coronavirus stood at 2,416,135 globally while the death toll has reached 165,939.

Topics in this article: